Nancy Ryan Gray Ligand Pharmaceuticals Inc (LGND) insider trading activity

LGND Quotes by TradingView

Nancy Ryan Gray is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 8,094 shares of LGND, which is worth approximately $911,060. The most recent transaction as insider was on Jun 06, 2025, when has been sold 1,209 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.09K
17.56% 3M change
17.56% 12M change
Total Value Held $911,060

Nancy Ryan Gray Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2025
BUY
Grant, award, or other acquisition
-
1,209 Added 13.0%
8,094 Common Stock
Jun 14 2024
BUY
Grant, award, or other acquisition
-
1,252 Added 15.39%
6,885 Common Stock
May 09 2024
SELL
Open market or private sale
$77,708 $83.2 p/Share
934 Reduced 14.22%
5,633 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
1,142 Added 14.81%
6,567 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
1,004 Added 17.58%
4,706 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
630 Added 14.54%
3,702 Common Stock
NRG

Nancy Ryan Gray

Director
Emeryville, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LGND